Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.50p
   
  • Change Today:
    -0.050p
  • 52 Week High: 11.50
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 116,754
  • Market Cap: £52.50m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
62.19% below the market average62.19% below the market average62.19% below the market average62.19% below the market average62.19% below the market average
38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average38.78% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average77.43% above the market average
78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average78.95% above the sector average
Price Chg 3m
84.68% above the market average84.68% above the market average84.68% above the market average84.68% above the market average84.68% above the market average
89.47% above the sector average89.47% above the sector average89.47% above the sector average89.47% above the sector average89.47% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
58.32% above the market average58.32% above the market average58.32% above the market average58.32% above the market average58.32% above the market average
66.04% above the sector average66.04% above the sector average66.04% above the sector average66.04% above the sector average66.04% above the sector average
Momentum 20
31.62% above the market average31.62% above the market average31.62% above the market average31.62% above the market average31.62% above the market average
58.49% above the sector average58.49% above the sector average58.49% above the sector average58.49% above the sector average58.49% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
48.76% below the market average48.76% below the market average48.76% below the market average48.76% below the market average48.76% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
69.77% below the market average69.77% below the market average69.77% below the market average69.77% below the market average69.77% below the market average
14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average14.81% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
16.81% below the market average16.81% below the market average16.81% below the market average16.81% below the market average16.81% below the market average
16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average
Cash
21.15% above the market average21.15% above the market average21.15% above the market average21.15% above the market average21.15% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
19.78% above the market average19.78% above the market average19.78% above the market average19.78% above the market average19.78% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 10.50p
Change Today -0.050p
% Change -0.47 %
52 Week High 11.50
52 Week Low 6.55
Volume 116,754
Shares Issued 500.00m
Market Cap £52.50m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average60.24% below the market average
43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average43.4% below the sector average
Price Trend
94.50% above the market average94.50% above the market average94.50% above the market average94.50% above the market average94.50% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
09:12 100,000 @ 10.60p
08:59 11,385 @ 10.44p
08:30 1,284 @ 10.43p
08:21 2,788 @ 10.43p
08:14 6 @ 10.70p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page